111 related articles for article (PubMed ID: 26410243)
21. Thiopurine S-methyltransferase pharmacogenetics: genotype to phenotype correlation in the Slovenian population.
Milek M; Murn J; Jaksic Z; Lukac Bajalo J; Jazbec J; Mlinaric Rascan I
Pharmacology; 2006; 77(3):105-14. PubMed ID: 16691038
[TBL] [Abstract][Full Text] [Related]
22. A bioinformatics approach to the identification of novel deleterious mutations of human TPMT through validated screening and molecular dynamics.
Saxena S; Krishna Murthy TP; Chandrashekhar CR; Patil LS; Aditya A; Shukla R; Yadav AK; Singh TR; Samantaray M; Ramaswamy A
Sci Rep; 2022 Nov; 12(1):18872. PubMed ID: 36344599
[TBL] [Abstract][Full Text] [Related]
23. Cat red blood cell thiopurine S-methyltransferase: companion animal pharmacogenetics.
Salavaggione OE; Yang C; Kidd LB; Thomae BA; Pankratz VS; Trepanier LA; Weinshilboum RM
J Pharmacol Exp Ther; 2004 Feb; 308(2):617-26. PubMed ID: 14610243
[TBL] [Abstract][Full Text] [Related]
24. Thiopurine methyltransferase in acute lymphoblastic leukaemia: biochemical and molecular biological aspects.
Brouwer C; De Abreu RA; Keizer-Garritsen JJ; Lambooy LH; Ament K; ter Riet PG; van Wering ER; Trijbels FJ; Veerman AJ; Hoogerbrugge PM; Bökkerink JP
Eur J Cancer; 2005 Mar; 41(4):613-23. PubMed ID: 15737567
[TBL] [Abstract][Full Text] [Related]
25. Functional characterization of 23 allelic variants of thiopurine S-methyltransferase gene (TPMT*2 - *24).
Ujiie S; Sasaki T; Mizugaki M; Ishikawa M; Hiratsuka M
Pharmacogenet Genomics; 2008 Oct; 18(10):887-93. PubMed ID: 18708949
[TBL] [Abstract][Full Text] [Related]
26. The thiopurine S-methyltransferase gene locus -- implications for clinical pharmacogenomics.
McLeod HL; Siva C
Pharmacogenomics; 2002 Jan; 3(1):89-98. PubMed ID: 11966406
[TBL] [Abstract][Full Text] [Related]
27. Screening of thiopurine S-methyltransferase mutations by horizontal conformation-sensitive gel electrophoresis.
Alves S; Prata MJ; Ferreira F; Amorim A
Hum Mutat; 2000; 15(3):246-53. PubMed ID: 10679940
[TBL] [Abstract][Full Text] [Related]
28. A multiplexed allele-specific polymerase chain reaction assay for the detection of common thiopurine S-methyltransferase (TPMT) mutations.
Roberts RL; Barclay ML; Gearry RB; Kennedy MA
Clin Chim Acta; 2004 Mar; 341(1-2):49-53. PubMed ID: 14967158
[TBL] [Abstract][Full Text] [Related]
29. Augmenting clinical interpretability of thiopurine methyltransferase laboratory evaluation.
Demlova R; Mrkvicova M; Sterba J; Bernatikova H; Stary J; Sukova M; Mikuskova A; Chocholova A; Mladosievicova B; Soltysova A; Behulova D; Pilatova K; Zdrazilova-Dubska L; Valik D
Oncology; 2014; 86(3):152-8. PubMed ID: 24643197
[TBL] [Abstract][Full Text] [Related]
30. Pathogenic or not? And if so, then how? Studying the effects of missense mutations using bioinformatics methods.
Thusberg J; Vihinen M
Hum Mutat; 2009 May; 30(5):703-14. PubMed ID: 19267389
[TBL] [Abstract][Full Text] [Related]
31. Trinucleotide repeat variants in the promoter of the thiopurine S-methyltransferase gene of patients exhibiting ultra-high enzyme activity.
Roberts RL; Gearry RB; Bland MV; Sies CW; George PM; Burt M; Marinaki AM; Arenas M; Barclay ML; Kennedy MA
Pharmacogenet Genomics; 2008 May; 18(5):434-8. PubMed ID: 18408566
[TBL] [Abstract][Full Text] [Related]
32. Drug methylation in cancer therapy: lessons from the TPMT polymorphism.
Krynetski E; Evans WE
Oncogene; 2003 Oct; 22(47):7403-13. PubMed ID: 14576848
[TBL] [Abstract][Full Text] [Related]
33. High prevalence of polymorphism and low activity of thiopurine methyltransferase in patients with inflammatory bowel disease.
Larussa T; Suraci E; Lentini M; Nazionale I; Gallo L; Abenavoli L; Imeneo M; Costanzo FS; Cuda G; Luzza F
Eur J Intern Med; 2012 Apr; 23(3):273-7. PubMed ID: 22385887
[TBL] [Abstract][Full Text] [Related]
34. Exploring the impact of F270V mutation in the β-tubulin (Bos Taurus) structure and its function: a computational perspective.
Verma K; Ramanathan K
Biotechnol Lett; 2015 May; 37(5):1003-11. PubMed ID: 25631779
[TBL] [Abstract][Full Text] [Related]
35. The role of genetic variation in thiopurine methyltransferase activity and the efficacy and/or side effects of azathioprine therapy in dermatologic patients.
Snow JL; Gibson LE
Arch Dermatol; 1995 Feb; 131(2):193-7. PubMed ID: 7857117
[TBL] [Abstract][Full Text] [Related]
36. Assessment of thiopurine methyltransferase enzyme activity is superior to genotype in predicting myelosuppression following azathioprine therapy in patients with inflammatory bowel disease.
Winter JW; Gaffney D; Shapiro D; Spooner RJ; Marinaki AM; Sanderson JD; Mills PR
Aliment Pharmacol Ther; 2007 May; 25(9):1069-77. PubMed ID: 17439508
[TBL] [Abstract][Full Text] [Related]
37. Rapid genotyping of common deficient thiopurine S-methyltransferase alleles using the DNA-microchip technique.
Nasedkina TV; Fedorova OE; Glotov AS; Chupova NV; Samochatova EV; Maiorova OA; Zemlyakova VV; Roudneva AE; Chudinov AV; Yurasov RA; Kozhekbaeva JM; Barsky VE; Krynetskiy EY; Krynetskaia NF; Cheng C; Ribeiro RC; Evans WE; Roumyantsev AG; Zasedatelev AS
Eur J Hum Genet; 2006 Sep; 14(9):991-8. PubMed ID: 16724002
[TBL] [Abstract][Full Text] [Related]
38. Molecular analysis of the thiopurine S-methyltransferase alleles in Bolivians and Tibetans.
Lu HF; Shih MC; Hsueh SC; Chen CM; Chang JY; Chang JG
J Clin Pharm Ther; 2005 Oct; 30(5):491-6. PubMed ID: 16164497
[TBL] [Abstract][Full Text] [Related]
39. CRIMEtoYHU: a new web tool to develop yeast-based functional assays for characterizing cancer-associated missense variants.
Mercatanti A; Lodovichi S; Cervelli T; Galli A
FEMS Yeast Res; 2017 Dec; 17(8):. PubMed ID: 29069390
[TBL] [Abstract][Full Text] [Related]
40. Methylation of selenocysteine catalysed by thiopurine S-methyltransferase.
Urbančič D; Kotar A; Šmid A; Jukič M; Gobec S; Mårtensson LG; Plavec J; Mlinarič-Raščan I
Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):182-190. PubMed ID: 30308221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
